Table 2. Comparison of clinical manifestations of diarrhea in the LacFiTM-administered and control groups.
| LacFiTM-administered | Not administered (control) |
|
|---|---|---|
| Total number of neonatal Thoroughbreds | 101 | 29 |
| Number of neonatal Thoroughbreds exhibiting diarrhea * | 31 | 22 |
| Ratio of diarrhea in neonatal Thoroughbreds (%) | 30.7 | 75.9 |
| Duration of diarrhea (days) (mean ± standard error of the mean) ** | 7.4 ± 0.8 | 14.0 ± 3.2 |
* Number of neonatal Thoroughbreds exhibiting diarrhea in LacFiTM-administered group was significantly (P<0.01) lower than that in control group, judged by Fisher’s exact test. ** Duration of diarrhea of LacFiTM-administered group was significantly (P<0.001) shorter than that of control group, judged by Student’s t-test.